Exploratory analysis of HER2-positive/CLDN18.2-positive metastatic gastric and gastroesophageal junction cancer toward future therapeutic development2026-03-010 PRE AI OOkemoto, D. NNakayama, I. *SShitara, K. DOI:10.1016/j.esmogo.2026.100315OriginalOriginal request for helpShareSaveAbstract En